Formo is a Biotech company based in Berlin, Germany. It has raised $111M in total funding. Latest round: Series B.
Formo funding overview
Formo is a Biotech company based in Berlin, Germany. Formo has raised $111M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in September 2024. The round record for Formo runs through 2024; nothing later has been disclosed. Investors on record include Foodlabs, EQT Ventures, Lowercarbon Capital, Happiness Capital, Elevat3 Capital, M Ventures and 15 others. 21 distinct backers are named across the disclosed rounds.
Formo at a glance
Total raised
$111M
Latest round
Series B
Latest round date
September 2024
Industry
Biotech
Headquarters
Berlin, Germany
Notable investors
Foodlabs, EQT Ventures, Lowercarbon Capital, Happiness Capital, Elevat3 Capital, M Ventures, Grazia Capital, Sazaby League
Frequently asked about Formo funding
How much has Formo raised?
Formo has raised $111M in total disclosed funding across the rounds on record.
Who has invested in Formo?
Foodlabs, EQT Ventures, Lowercarbon Capital, Happiness Capital, Elevat3 Capital, M Ventures are named among the investors backing Formo.
What was the latest Formo funding round?
The most recent disclosed round is a Series B, announced in September 2024.
Where is Formo based?
Formo is based in Berlin, Germany.
What sector does Formo operate in?
Formo is tracked under Biotech from Berlin, Germany, with $111M in disclosed funding.
When did Formo last raise?
The last disclosed Formo round closed in September 2024 at Series B.
Formo totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in Berlin below to benchmark round size and investor mix.
